Summary and Comparison of the 2022 ACC/AHA/ HFSA and 2021 ESC Heart Failure Guidelines

被引：2

作者：

Badger, Sarah ^{[1
]}

McVeigh, James ^{[1
]}

Indraratna, Praveen ^{[1
,2
]}

机构：

[1] Prince Wales Hosp, Dept Cardiol, Randwick, NSW, Australia

[2] UNSW, Sch Clin Med, Sydney, NSW, Australia

来源：

CARDIOLOGY AND THERAPY | 2023年 / 12卷 / 04期

关键词：

Heart failure; Heart failure with preserved ejection fraction; Heart failure with reduced ejection fraction; Guideline directed medical therapy; Clinical trials; CARDIAC-RESYNCHRONIZATION THERAPY; VENTRICULAR SYSTOLIC DYSFUNCTION; PRESERVED EJECTION FRACTION; DEFIBRILLATOR IMPLANTATION; CARDIOVASCULAR OUTCOMES; MORTALITY; REDUCTION; DIGOXIN; LIFE; IVABRADINE;

D O I：

10.1007/s40119-023-00328-3

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The guidelines released by the American College of Cardiology/American Heart Association/Heart Failure Society of America (ACC/AHA/HFSA) in 2022 and those released in 2021 by the European Society of Cardiology (ESC) play a crucial role in offering evidence-based recommendations for the diagnosis and management of heart failure (HF). This comprehensive review aims to provide an overview of these guidelines, incorporating insights from relevant clinical trials. While there is considerable alignment between the two sets of guidelines, certain notable differences arise due to variations in publication timelines, which we will outline. By presenting this summary, our objective is to empower clinicians to make informed decisions regarding HF management in their own practice, and facilitate the development of more harmonized guidelines in the future.

引用

页码：571 / 588

页数：18

共 56 条

[1] Cardiac resynchronization in chronic heart failure [J].

Abraham, WT ;

Fisher, WG ;

Smith, AL ;

Delurgio, DB ;

Leon, AR ;

Loh, E ;

Kocovic, DZ ;

Packer, M ;

Clavell, AL ;

Hayes, DL ;

Ellestad, M ;

Messenger, J ;

Trupp, RJ ;

Underwood, J ;

Pickering, F ;

Truex, C ;

McAtee, P .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (24) :1845-1853

[2] Lifestyle Modifications for Preventing and Treating Heart Failure [J].

Aggarwal, Monica ;

Bozkurt, Biykem ;

Panjrath, Gurusher ;

Aggarwal, Brooke ;

Ostfeld, Robert J. ;

Barnard, Neal D. ;

Gaggin, Hanna ;

Freeman, Andrew M. ;

Allen, Kathleen ;

Madan, Shivank ;

Massera, Daniele ;

Litwin, Sheldon E. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (19) :2391-2405

[3] Digoxin and reduction in mortality and hospitalization in heart failure:: a comprehensive post hoc analysis of the DIG trial [J].

Ahmed, A ;

Rich, MW ;

Love, TE ;

Lloyd-Jones, DM ;

Aban, IB ;

Colucci, WS ;

Adams, KF ;

Gheorghiade, M .

EUROPEAN HEART JOURNAL, 2006, 27 (02) :178-186

[4] The Use of Digoxin in Patients With Worsening Chronic Heart Failure Reconsidering an Old Drug to Reduce Hospital Admissions [J].

Ambrosy, Andrew P. ;

Butler, Javed ;

Ahmed, Ali ;

Vaduganathan, Muthiah ;

van Veldhuisen, Dirk J. ;

Colucci, Wilson S. ;

Gheorghiade, Mihai .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (18) :1823-1832

[5] Empagliflozin in Heart Failure with a Preserved Ejection Fraction [J].

Anker, Stefan D. ;

Butler, Javed ;

Filippatos, Gerasimos ;

Ferreira, Joao P. ;

Bocchi, Edimar ;

Boehm, Michael ;

Brunner-La Rocca, Hans-Peter ;

Choi, Dong-Ju ;

Chopra, Vijay ;

Chuquiure-Valenzuela, Eduardo ;

Giannetti, Nadia ;

Gomez-Mesa, Juan Esteban ;

Janssens, Stefan ;

Januzzi, James L. ;

Gonzalez-Juanatey, Jose R. ;

Merkely, Bela ;

Nicholls, Stephen J. ;

Perrone, Sergio V. ;

Pina, Ileana L. ;

Ponikowski, Piotr ;

Senni, Michele ;

Sim, David ;

Spinar, Jindrich ;

Squire, Iain ;

Taddei, Stefano ;

Tsutsui, Hiroyuki ;

Verma, Subodh ;

Vinereanu, Dragos ;

Zhang, Jian ;

Carson, Peter ;

Lam, Carolyn Su Ping ;

Marx, Nikolaus ;

Zeller, Cordula ;

Sattar, Naveed ;

Jamal, Waheed ;

Schnaidt, Sven ;

Schnee, Janet M. ;

Brueckmann, Martina ;

Pocock, Stuart J. ;

Zannad, Faiez ;

Packer, Milton .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) :1451-1461

[6]

[Anonymous], 2020, AUSTR MED HDB 2020

[7] Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction [J].

Armstrong, Paul W. ;

Pieske, Burkert ;

Anstrom, Kevin J. ;

Ezekowitz, Justin ;

Hernandez, Adrian F. ;

Butler, Javed ;

Lam, Carolyn S. P. ;

Ponikowski, Piotr ;

Voors, Adriaan A. ;

Jia, Gang ;

McNulty, Steven E. ;

Patel, Mahesh J. ;

Roessig, Lothar ;

Koglin, Joerg ;

O'Connor, Christopher M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20) :1883-1893

[8]

Bardy GH, 2005, NEW ENGL J MED, V352, P2146

[9] Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With Ivabradine in Stable Heart Failure (from the SHIFT Trial) [J].

Boehm, Michael ;

Robertson, Michele ;

Ford, Ian ;

Borer, Jeffrey S. ;

Komajda, Michel ;

Kindermann, Ingrid ;

Maack, Christoph ;

Lainscak, Mitja ;

Swedberg, Karl ;

Tavazzi, Luigi .

AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (12) :1890-1897

[10] Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study [J].

Boehm, Michael ;

Borer, Jeffrey ;

Ford, Ian ;

Gonzalez-Juanatey, Jose R. ;

Komajda, Michel ;

Lopez-Sendon, Jose ;

Reil, Jan-Christian ;

Swedberg, Karl ;

Tavazzi, Luigi .

CLINICAL RESEARCH IN CARDIOLOGY, 2013, 102 (01) :11-22

← 1 2 3 4 5 6 →